[1]刘斌,杨玉霞,刘杏,等. 雷珠单抗联合Ahmed青光眼阀植入术治疗新生血管性青光眼[J].眼科新进展,2015,35(3):263-265.[doi:10.13389/j.cnki.rao.2015.0070]
　LIU Bin,YANG Yu-Xia,LIU Xing,et al. Intravitreal lucentis injection combined with Ahmed valve implantation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(3):263-265.[doi:10.13389/j.cnki.rao.2015.0070]
点击复制

 雷珠单抗联合Ahmed青光眼阀植入术治疗新生血管性青光眼
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
35卷
期数:
2015年3期
页码:
263-265
栏目:
应用研究
出版日期:
2015-03-05

文章信息/Info

Title:
 Intravitreal lucentis injection combined with Ahmed valve implantation for neovascular glaucoma
作者:
 刘斌; 杨玉霞; 刘杏; 李伟力; 莫正政
 518000　广东省深圳市，深圳爱视眼科专科门诊部
Author(s):
 LIU Bin ; YANG Yu-Xia ;  LIU Xing ;  LI Wei-Li ;  MO Zheng-Zheng
 Eyeis Ophthalmology of Shenzhen. Shenzhen 518000, Guangdong Province, China
关键词:
 ; 雷珠单抗; Ahmed青光眼阀; 新生血管性青光眼
Keywords:
 ; lucentis ;  Ahmed valve implantation;  neovascular glaucoma
DOI:
10.13389/j.cnki.rao.2015.0070
文献标志码:
A
摘要:
 目的　观察玻璃体腔注射雷珠单抗联合Ａｈｍｅｄ青光眼阀植入术对新生血管性青光眼的治疗效果。方法　选择药物无法控制眼压的新生血管性青光眼患者１８例１８眼，先给予患眼玻璃体腔注射雷珠单抗０．０５ｍＬ，于注药１周后行Ａｈｍｅｄ青光眼阀植入术，并于术后及时行眼底荧光血管造影及视网膜激光光凝术。结果　注药后２～７ｄ，１６眼新生血管全部消退，２眼残留少许血管。玻璃体腔注药前眼压为３８．０～５９．０（４８．５±９．５）ｍｍ-Ｈｇ（１ｋＰａ＝７．５ｍｍＨｇ），注药后１周眼压为３６．５～５９．０（４７．８±１１．３）ｍｍＨｇ，注药前后眼压变化差异无统计学意义（Ｐ＞０．０５）。青光眼阀植入术后随访１ａ，１４例患者眼压控制在正常范围，４例患者眼压出现不同程度升高。青光眼阀植入术前后眼压变化差异有统计学意义（Ｐ＜０.０１）。青光眼阀植入术后视力提高者８例，视力无明显变化者１０例。结论　玻璃体腔注射雷珠单抗联合Ａｈｍｅｄ青光眼阀植入术治疗新生血管性青光眼安全有效。
Abstract:
 Objective To evaluate the clinical therapeutic efficacy of intravitreal lucentis injection combined with Ahmed valve implantation for neovascular glaucoma ( NVG) . Methods Eighteen confirmed cases ( 18 eyes) with NVG . whose IOP could not be controlled by antiglaucoma medication .were received intravitreal injection of lucentis . after I week the Ahmed valve implantation were performed. Then the FFA and the retinal laser photocoagulation treatment were taken. Results The iris neovessels were regressed in 16 cases from 2 days t0 7 days after the intravitreal injection of lucentis , and 2 cases remained a few fine neovessels. The intraocular pressure ( IOP) before injection was 38. 0 - 59. 0 ( 48. 5 +9. 5 ) mmHg ( I kPa = 7. 5 mmHg) ,1 week after injection was 36. 5 - 59. 0 ( 47. 8 + 11. 3 ) mmHg , there was no statistical difference ( P > 0. 05 ) . After a follow-up of one year,IOP in 14 cases were controlled in normal.4 cases were increased. There was sigruficant difference in IOP before and after Ahmed valve implantation ( P < 0. 01 ) . The visual acuity in 8 cases were increased after Ahmed valve implantation.unchanged in 10 cases. Conclusion The intravitreal lucentis injection combined with Ahmed valve implantation for NVG is safe and effective.

相似文献/References:

[1]李姣 王兴荣 崔彦 刘正峰 王影 李洋.雷珠单抗选择性体外抑制睫状体恶性黑色素瘤[J].眼科新进展,2013,33(11):000.
[2]刘平 苏胜. 白内障蛋白质组学研究的现状及未来研究方向[J].眼科新进展,2014,34(1):001.
[3]杨宝娣 宋艳萍 陈中山 丁琴. 微脉冲半导体激光对兔视网膜色素上皮细胞阈值下光凝的光生物调制效应[J].眼科新进展,2014,34(1):005.
[4]赖伟霞 梁皓 谭少健 李霞 邹文进 蒋林志. 钙调素在正常人及不同年龄白内障患者晶状体上皮细胞中的表达[J].眼科新进展,2014,34(1):010.
[5]郑燕林 刘聪慧 沙菽. 水蛭提取液对体外培养RF/6A的细胞液中MMP-2、IV型胶原含量的影响[J].眼科新进展,2014,34(1):013.
[6]周琨 高晓唯 蔡岩 李文静 胡裕坤 田丽丽 付燕. CCR7基因修饰的未成熟树突状细胞在大鼠高危角膜移植免疫排斥反应中的作用[J].眼科新进展,2014,34(1):017.
[7]高伟 程燕 吴洁 王亮 赵帅. 肉毒杆菌B诱导大鼠干眼模型中泪腺Lacritin蛋白表达的研究[J].眼科新进展,2014,34(1):021.
[8]赵宁 张瑞君 刘磊 李佳 刘宁宁. PTEN基因对兔晶状体上皮细胞增殖抑制作用的实验研究[J].眼科新进展,2014,34(1):025.
[9]陈雪 李海平 张培 曹安民. 小胶质细胞在视网膜母细胞瘤中的活化及分布研究[J].眼科新进展,2014,34(1):029.
[10]李琴 谢婷玉 陈雪艺 王清 郭乔茜 具尔提·哈第尔. 臭氧灌肠改善糖尿病大鼠的视网膜电图表现[J].眼科新进展,2014,34(1):034.
[11]张聪,刘东宁,徐丽. 玻璃体内注射Lucentis治疗中心性渗出性脉络膜视网膜病变的临床疗效[J].眼科新进展,2014,34(9):864.[doi:10.13389/j.cnki.rao.2014.0239]
[12]王博,吴京,马明,等. 玻璃体内注射雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效对比分析[J].眼科新进展,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
　WANG Bo,WU Jing,MA Ming,et al. Clinictid effect comparison of intravitreal lucentis and triamcinolone acetonide for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
[13]刘志南,邓国华,江一. 光凝前雷珠单抗玻璃体内注射对CNV患者黄斑区视网膜及视功能的影响[J].眼科新进展,2015,35(4):365.[doi:10.13389/j.cnki.rao.2015.0098]
　LIU Zhi-Nan,DENG Guo-Hua,JIANG Yi. Effects of ranibizumab intravitreal injection before photocoagulation on macular retina and visual function in patients with CNV[J].Recent Advances in Ophthalmology,2015,35(3):365.[doi:10.13389/j.cnki.rao.2015.0098]
[14]万文萃,刘宇莹,尹向可,等. 玻璃体内注射抗血管内皮生长因子药物治疗急进性后部型早产儿视网膜病变[J].眼科新进展,2015,35(6):554.[doi:10.13389/j.cnki.rao.2015.0150]
　WAN Wen-Cui,LIU Yu-Ying,YIN Xiang-Ke,et al. Intravitreal injection of ranibizumab for aggressive posterior retinopathy of prematurity[J].Recent Advances in Ophthalmology,2015,35(3):554.[doi:10.13389/j.cnki.rao.2015.0150]
[15]李素华,高永峰. 比较单独黄斑局灶/格栅样光凝术和联合雷珠单抗治疗糖尿病性黄斑水肿的疗效[J].眼科新进展,2015,35(6):566.[doi:10.13389/j.cnki.rao.2015.0153]
　LI Su-Hua,GAO Yong-Feng. Efficacy of macular focal / grid photocoagulation combined with ranibizumab for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(3):566.[doi:10.13389/j.cnki.rao.2015.0153]
[16]徐浩,白宁艳,吕鹏,等. 雷珠单抗玻璃体内注射与黄斑部格栅样光凝联合治疗糖尿病性黄斑水肿的疗效观察[J].眼科新进展,2015,35(8):781.[doi:10.13389/j.cnki.rao.2015.0215]
　XU Hao,BAI Ning-Yan,LV Peng,et al. Intravitreous injection of ranibizumab combined with macular grid photocoagulation for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(3):781.[doi:10.13389/j.cnki.rao.2015.0215]
[17]周琼,肖昂. 雷珠单抗对糖尿病大鼠早期视网膜组织结构的影响[J].眼科新进展,2015,35(9):827.[doi:10.13389/j.cnki.rao.2015.0226]
　ZHOU Qiong,XIAO Ang. Effects of ranibizumab on retinal structure at early stage of diabetic rats[J].Recent Advances in Ophthalmology,2015,35(3):827.[doi:10.13389/j.cnki.rao.2015.0226]

备注/Memo

备注/Memo:
 广东省医学科研基金（编号：Ｂ２０１３１３９）；佛山市医学类科技攻关项目（编号：２０１３０８０９８）
更新日期/Last Update: 2015-03-04